Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 788. The contact email is not on this page.
- APPLIED BIOTECHNOLOGY INSTITUTE
NIH R43: Production of low-cost heat stable forms of adalimumab in maize for treatment of inflammatory bowel disease.
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ADVANCED TACTILE IMAGING, INC.
NIH R44: Cervix monitor for risk assessment of spontaneous preterm delivery
startup · NJ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AEROSOL DYNAMICS, INC.
NIH R44: Biocascade inlet
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NeuroDex Inc
Form D history: Biotechnology
startup · MA · amount not stated · 2023-05-02
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-05-02.
- COLLABORATIONS PHARMACEUTICALS, INC.
NIH R44: Machine learning approaches to predict Acetylcholinesterase inhibition and model applications
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NOUR HEART, INC.
NIH R44: Nourexal™: A Novel Bioenergetic Drug to Increase Donor Heart Utilization
startup · VA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TRACE-ABILITY, INC.
NIH R44: Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EDVOTEK, INC.
NIH R43: The STEMfluidics Platform: Inspiring STEM Learning and Career Exploration with Microfluidics
startup · DC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GLYCIOME, LLC
NIH R44: Cervical Cancer Prevention Prebiotic Device
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SYNCARDIA SYSTEMS, LLC
NIH R43: A wearable, mechanically actuated total artificial heart (Emperor) enabling destination therapy for severe biventricular heart failure patients
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SHIP OF THESEUS, LLC
NIH R44: Stimulant for stem cell expansion in vivo to speed recovery of neutropenia secondary to chemotherapy and stem cell transplant
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Shifa Biomedical Corp
Form D history: Biotechnology
startup · PA · amount not stated · 2021-05-14
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2021-05-14.
- AEON IMAGING, LLC
NIH R41: Lowering the cost of improved measurements of VA in real-world older patients
startup · IN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VIRSCIO, INC.
NIH R43: Primate epigenetic and senescence biomarkers to advance aging science and anti-aging strategies.
startup · CT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VOICELOVE INC.
NIH R42: VoiceLove: An App-Based COMmunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LASARRUS CLINIC AND RESEARCH CENTER, INC.
NIH R44: Bilateral Acoustic Sensing and Automated Breathing Segmentation for Remote Monitoring of Patients with COPD: A Longitudinal Study
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- IMMUNYX PHARMA USA INC.
NIH R44: Development of IMYX-3 for the Treatment of Ulcerative Colitis
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Kano Therapeutics
Kano Therapeutics specializes in circular single-stranded DNA (cssDNA) for genetic medicine, providing innovative solutions for gene therapy and editing through scalable manufacturing processes.
startup · MA · amount not stated · 2024-05-20
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-05-20.
- BIOSYFT INC.
NIH R41: AI-Driven Detection of Addiction-Like Reward Signatures Through Automated Multi-View Behavioral Analysis
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Primrose Bio, Inc.
Form D history: Biotechnology
startup · CA · amount not stated · 2024-07-17
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-07-17.
- RIP ROAD, INC.
NIH R42: The Assessment of Smart Phone Everyday Tasks (ASSET): A new IADL test for early AD
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ELECTRONIC BIOSCIENCES, INC.
NIH R41: High-Resolution Pseudouridine and m6A Sequencing Through Advanced Nanopore Adduct Analysis
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BELLWETHERS INC.
NIH R43: Rejuvenis: A Partially Reprogramming Small Molecule Drug for Brain Rejuvenation and Alzheimer's Disease Therapy
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CIBOTS, INC.
NIH R43: Xylazine and opioid overdose mitigation therapy using decoy receptor biomimetic nanoparticles, NarcoBond platform
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ADVANCED & INNOVATIVE MULTIFUNCTIONAL MATERIALS LLC
NIH R43: Short Chain PFAS Adsorption via AimmSorb
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- APPLIED DESIGN TECHNOLOGIES
NIH R43: ClearWorks Particulate Respirator
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RUMI SCIENTIFIC, INC.
NIH R44: An Integrated Drug Discovery Platform for Neurodevelopmental Disorders Using Standardized Self-Organizing Human Cerebroids
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CONVERGENT ENGINEERING, INC.
NIH R43: Decision Support System for Personalized Care of Ventilated Patients using Esophageal Pressure
startup · FL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RYTEK MEDICAL, INC.
NIH R43: Impedance-based bone health characterization for predictive osseointegration and patient-specific treatment
startup · NH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PRO-CHANGE BEHAVIOR SYSTEMS, INC.
NIH R43: Bridges: A digital intervention to increase workplace belonging
startup · RI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AUST DEVELOPMENT, LLC
NIH R43: Precision Lead Delivery for Advanced Conduction System Pacing
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SPOTTED TECH LLC
NIH R41: CD4-LINK: Improving access to HIV care in underserves areas with a home-based, mail-in CD4 count test
startup · LA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VECTECH, LLC
NIH R43: Automated identification of larval mosquito species with computer vision
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SIERRA BIOPHARMA, INC.
NIH R43: Antigen specific treatment of AChR myasthenia gravis with an engineered biologic
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- OMAROON CORPORATION
NIH R43: Miniaturization and Human-Centered Design of an AI-Enabled At-Home PKU Monitoring System for Children
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- OLERA INC.
NIH R44: Olera CareNavigator - Increasing Affordability and Accessibility of Senior Care For Dementia Family Caregivers
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PROMILEAD, LLC
NIH R41: Activating TFEB to enhance the efficacy of immunotherapy for triple negative breast cancer
startup · SC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MATERIALS NOVA LIMITED LIABILITY COMPANY
NIH R41: Ultra-Sensitive, Rapid, Point-of-Use (POU) Mercury Sensor Enabled by Light-Pinpointed Enrichment
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BROOKLYN INNOSEQ INC.
NIH R43: Development and Validation of a Non-Invasive Microbiome-Based Diagnostic Tool for Early Detection of Gestational Diabetes Mellitus
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AVANTGEN, INC.
NIH R44: A novel approach for treating myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.